knockdown impeded tumor growth in vivo and increased miR-122-5p expression. Conclusion Our finding suggested that knockdown of ANRIL suppressed cell proliferation, metastasis and invasion via regulating miR-122-5p expression in HCC, illustrating the underlying mechanism of the oncogenic role of ANRIL in HCC.
Introduction
Hepatocellular carcinoma (HCC) is believed to be one of the most frequent malignancies worldwide to impact human health, accounting for approximately 80-90% of liver cancer cases (Eltawansy et al. 2015) . HCC has been reported to be the third leading cause of cancer-associated mortality and lead to approximately 662,000 deaths each year worldwide (Xie et al. 2013) . In spite of the therapeutic advances in diagnosis and clinical treatment for HCC in recent years, the prognosis of patients suffering from HCC remains unsatisfactory and the 5-year survival rate is still approximately 7% (Huang et al. 2015a; Tan et al. 2010; Tian et al. 2016) . Patients with HCC are frequently characterized by aggressive tumor metastasis, invasion, and postoperative recurrence prior to a definite diagnosis (Cui et al. 2015; Li et al. 2014) . Therefore, it is imperative to identify specific prognostic markers and better understand the underlying molecular mechanisms involved in the metastasis and progression of HCC.
In recent years, non-coding RNAs (ncRNAs), mainly including two groups based on their size: small ncRNAs (< 200 nt) and long ncRNAs (lncRNAs), have been extensively identified as novel clinical biomarkers and potential therapeutic targets for various tumors (Cho 2010; Mercer et al. 2009 ). microRNAs (miRNAs) belong to highly conserved small ncRNAs with 20-25 nucleotides in length that directly bind to the 3′-untranslated region (3′-UTR) of target mRNAs to participate in the regulation of various biological processes, such as cell proliferation, differentiation, apoptosis, and metastasis (Krol et al. 2010) . It has been proposed that several miRNAs are implicated in the pathogenesis and development of HCC by regulating tumor oncogenes or suppressor genes (Gao et al. 2015; Yao et al. 2016; Zhao et al. 2016) . LncRNAs are classified as RNA molecules with more than 200 nucleotides in length and limited proteincoding potential (Nagano and Fraser 2011) . LncRNAs were reported to play critically important roles in a wide range of physiological and pathological processes, including development, differentiation, as well as tumor pathogenesis (Kung et al. 2013; Serviss et al. 2014) . Intriguingly, lncRNAs have been demonstrated to be frequently aberrantly expressed in multiple cancers, including HCC, which contributes to the carcinogenesis, development, and prognosis of HCC (Mathieu et al. 2014; Xiao et al. 2017) .
LncRNA antisense non-coding RNA in the INK4 locus (ANRIL), also known as CDKN2B-AS, is transcribed as a 3.8 kb lncRNA that contains 19 exons in the antisense direction of the INK4B-ARF-INK4A gene cluster at chromosome 9p21, which has been identified as a shared genetic susceptibility region related to several human diseases including cancers (Pasmant et al. 2007; Yap et al. 2010) . It is well documented that ANRIL was upregulated and exerted oncogenic activity in several human malignancies, such as bladder cancer, epithelial ovarian cancer, and non-small cell lung cancer cell (Naemura et al. 2015; Nie et al. 2015; Qiu et al. 2016; Zhu et al. 2015b ). Notably, the previous studies reported that ANRIL was upregulated in HCC tissues, which was associated with poor prognosis in HCC, and decreased expression of ANRIL could suppress cell proliferation, metastasis and invasion and induce apoptosis of HCC cells (Hua et al. 2015; Huang et al. 2015b) . Recently, accumulating evidence has suggested that lncRNAs may act as competing endogenous RNAs (ceRNAs), namely, miRNA sponges or antagomirs, to interact with miRNAs and downregulate miRNA expressions and activities (Cesana et al. 2011; Salmena et al. 2011; Wang et al. 2013) . Therefore, we proposed whether ANRIL also has roles as miRNA sponges to regulate the function of miRNAs in HCC.
In the present study, we found that ANRIL was upregulated in HCC tissues and negatively correlated with miR-122-5p expression. Furthermore, miR-122-5p was predicted to contain complementary bases pairing with ANRIL by the online bioinformatics software Starbase 2.0 (http://starbase.sysu.edu.cn/mirLncRNA.php), and downregulation of ANRIL suppressed cell proliferation, metastasis, and invasion by regulating miR-122-5p. We hypothesized that ANRIL may serve as miR-122-5p sponge to regulate the function of miR-122-5p in HCC.
Materials and methods

Tissue samples
A total of 31 human HCC tissue specimens and corresponding adjacent normal tissue specimens were consecutively collected from patients undergoing surgical resection at the First Affiliated Hospital of Zhengzhou University between Sep 2014 and Dec 2016. All HCC patients did not receive any treatments including chemotherapy, radiotherapy, or any other medical intervention prior to the surgery and were diagnosed based on pathological evidence. The collected tissues were immediately snap-frozen in liquid nitrogen after resection and preserved in liquid nitrogen until RNA extraction. Written informed consent was obtained from each participant and the study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University.
Cell lines and transfection
The HCC cell lines (SMMC772, HUH7, Hep3B, and HepG2) and normal hepatic cell line LO2 were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). All cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Carlsbad, CA, USA) containing 10% heat-inactivated fetal bovine serum (FBS; Sigma, St. Louis, MO, USA) and 1% penicillin/streptomycin (HyClone, Logan, Utah, USA) in a humidified incubator containing 5% CO 2 at 37 °C.
miR-122-5p mimics (miR-122-5p), control miRNA (miR-NC), pcDNA-ANRIL, pcDNA empty vector (vector), siRNA against ANRIL (si-ANRIL), scrambled negative control (si-NC), short-hairpin RNA plasmid directly knocking down ANRIL (sh-ANRIL), or its non-targeting sequence (sh-NC) was chemically synthesized by GenePharma (Shanghai, China). Oligonucleotide or plasmid transfection into HCC cells was carried out using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Cells were collected for further experiments at 48 h after transfection.
Total RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from tissue specimens and cultured cells using the Trizol reagent (Invitrogen). For the detection of ANRIL and miR-122-5p expressions, cDNA synthesis from 2 µg of total RNA was performed using an MMLV RT reagent kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA) or PrimeScript® miRNA (TaKaRa, Tokyo, Japan), respectively. RT-PCR was performed with SYBR-Green Real-Time Master Mix (Toyobo, Co., Ltd, Osaka, Japan) on an Applied Biosystems 7500 real-time PCR platform (Applied Biosystems, Foster City, CA, USA). The relative expressions of ANRIL and miR-122-5p were calculated by the 2 −ΔΔCT value method and normalized to GAPDH and U6, respectively. The specific primers used for RT-PCR included: ANRIL, 5′-TTG TGA AGC CCA AGT ACT GC-3′(forward), 5′-TTC ACT GTG GAG ACG TTG GT-3′(reverse); GAPDH, 5′-AGC CAC ATC GCT CAG ACA -3′ (forward), 5′-TGG ACT CCA CGA CGT ACT -3′ (reverse); miR-122-5p, 5′-GTG ACA ATG GTG GAA TGT GG-3′ (forward), 5′-AAA GCA AAC GAT GCC AAG AC-3′ (reverse); U6, 5′-CTC GCT TCG GCA GCACA-3′ (forward), 5′-AAC GCT TCA CGA ATT TGC GT-3′ (reverse).
Cell proliferation assay
Cell viability was assessed by 3-(4,5)-dimethyl thiahiazo-(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay as described previously (van Meerloo et al. 2011) . Briefly, the transfected HCC cells were seeded in 96-well plate with quadruplicate repeat at a density of 8,000 cells per well the day before transfection and routinely cultured for 48 h. Subsequently, cells were incubated with 20 μl MTT (5 mg/ml; Sigma) at 37 °C for another 4 h. At the end of incubation, the culture medium was removed and 150 μl of dimethyl sulfoxide (DMSO; Sigma) was added to dissolve the crystals. The absorbance value at 490 nm was measured using an FL600 fluorescence plate reader (Bio-Rad, Hercules, CA, USA).
Plate clone formation assay
The transfected cells (2 × 10 3 /well) were seeded in six-well plates and incubated in DMEM medium containing 10% FBS at 37 °C with 5% CO 2 for 14 days. Subsequently, the cells were fixed with 4% paraformaldehyde for 30 min and then stained with 0.1% crystal violet (Beyotime, Shanghai, China) for 30 min. The number of colonies containing ≥ 50 cells was counted and representative images were obtained.
Transwell invasion assay
The 24-well transwell chambers with 8-µm pore size (BD Biosciences, San Jose, CA, USA) were used to evaluate cell invasion potential. In brief, the transfected HCC cells (2 × 10 5 cells/well in 100 µl serum-free culture medium) were seeded into the upper Matrigel-coated chamber (BD Biosciences), while the bottom chambers were filled up with the corresponding media containing 10% FBS as a chemoattractant. After incubation for 48 h, the non-invading cells in the upper chamber were scraped by cotton swabs. The invading cells on the bottom were fixed in 4% paraformaldehyde and dyed with 0.1% crystal violet (Beyotime). Cells were counted and photographed in five random fields under an inverted microscope (Olympus, Tokyo, Japan; 40× magnification).
Wound healing assay
The transfected HCC cells (1 × 10 6 /well) in logarithmic phase were inoculated into 6-well plates and grown to 90% confluence. Cell monolayers were then scratched by a 10-μl sterile pipette tip and washed gently with PBS three times. Then, fresh medium was replenished for an additional incubation of 24 h. The wound areas were imaged at 0 and 24 h with an inverted microscope (Olympus) and quantified using the Image-Pro Plus v. 6.0 software (Media Cybernetics, Bethesda, MD, USA).
Luciferase reporter assay
The fragment of ANRIL containing the predicted wildtype or mutated miR-122-5p-binding sites (ANRIL-WT or ANRIL-MUT) were synthesized by PCR and cloned into the pmirGLO-basic luciferase reporter vector (Promega, Madison, WI,USA), namely, pmirGLO-ANRIL-WT and pmirGLO-ANRIL-MUT. For luciferase reporter assay, HCC cells were cotransfected with 100-ng constructed luciferase reporter vectors, together with 20-ng Renilla luciferase vector (Promega) and 100-nM miR-122-5p, or miR-NC using Lipofectamine 2000 (Invitrogen). At 48-h posttransfection, cells were collected and the activities of Renilla and firefly luciferase were measured using the Dual-Luciferase Reporter assay system (Promega). The Renilla luciferase activity was used as the normalization.
RNA immunoprecipitation (RIP) assay
The RIP assay was performed as previously described (Yuan et al. 2014) . HCC cells were cotransfected with pcDNA-MS2, pcDNA-MS2-ANRIL-WT, or pcDNA-MS2-ANRIL-MUT and pMS2-GFP (Addgene, Cambridge, Massachusetts, USA). At 48-h posttransfection, cells were subjected to RIP assays using the Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA, USA) following the manufacturer's instructions. Cells were lysed by RIP lysis buffer containing a protease inhibitor cocktail and RNase inhibitor. Whole cell extract was subsequently incubated with RIP buffer containing magnetic beads conjugated with anti-GFP antibody (Abcam, Cambridge, MA, USA) or anti-rabbit IgG (Abcam) for 1 h at room temperature. Samples were incubated with Proteinase K to dissolve the protein, and then, immunoprecipitated RNA was isolated. The coprecipitated RNAs were detected by qRT-PCR.
Tumor xenograft formation assay
Female BALB/C athymic nude mice with 4 weeks were purchased from the National Laboratory Animal Center (Beijing, China). The animal experimental protocols were approved by animal Ethics Committee of the First Affiliated Hospital of Zhengzhou University. HepG2 cells (1 × 10 6 ) transfected with sh-ANRIL or sh-NC were subcutaneously injected at 100-µL cell suspension per injection into either side of flank area of nude mice (n = 4 per group) and then housed in specific pathogen free facilities. Tumor volumes were measured once every 5 days for 35 days and calculated using the following formula: 0.5 × length × width × height. By 35 days after injection, all mice were killed and tumors were dissected and weighted. The expression level of miR-122-5p in resected tumors was analyzed by qRT-PCR.
Statistical analysis
Data were presented as mean ± standard deviation (SD). All results were analyzed with GraphPad Prism 5 using student's t tests or one-way ANOVA. Differences were considered to be a statistical significance at a P value of < 0.05.
Results
The expressions of ANRIL and miR-122-5p in HCC tissues
To determine whether ANRIL and miR-122-5p were dysregulated in HCC, qRT-PCR was performed to evaluate the expression levels of ANRIL and miR-122-5p in 31 paired HCC tissues and their corresponding adjacent normal tissues. As shown in Fig. 1a , b, ANRIL expressed exceptionally higher (P = 0.0009) and miR-122-5p expressed markedly lower (P = 0.0017) in HCC tissues than their corresponding adjacent normal tissues. Interestingly, a negative correlation between ANRIL and miR-122-5p was observed in HCC tissues (R = − 0.5906, P = 0.0013, Fig. 1c ).
The expressions of ANRIL and miR-122-5p in HCC cells
The expression levels of ANRIL and miR-122-5p in HCC cell lines were further investigated by qRT-PCR. As compared with normal hepatic cell line LO2, HCC cell lines including SMMC7721, HUH7, Hep3B, and HepG2 exhibited significantly higher levels of ANRIL expression (Fig. 2a) and dramatically lower levels of miR-122-5p expression (Fig. 2b) .
The effect of ANRIL knockdown on HCC cell growth, metastasis and invasion
To elucidate the biological role of ANRIL in HCC progression, siRNA-mediated ANRIL knockdown in HepG2 and SMMC7721 cells was performed. Cell viability and clonogenic potential were determined by MTT assay and colony formation assay in si-ANRIL-transfected HCC cells, respectively. MTT assay suggested that ANRIL knockdown in both HepG2 and SMMC7721 cells led to an obvious reduction of cell viability relative to si-NC-transfected cells (Fig. 3a) . As demonstrated by colony formation assay, the colony numbers in si-ANRIL-transfected HepG2 and SMMC7721 cells were remarkably decreased compared with si-NC group (Fig. 3b) . These results revealed that ANRIL knockdown apparently blocked HCC cell growth. Next, wound healing assay and transwell invasion assay was applied to analyze the effects of ANRIL on HCC cell metastasis and invasion. As illustrated in Fig. 3c, d , ANRIL knockdown significantly impeded the mobility of HepG2 and SMMC7721 cells compared to the control groups, as (Fig. 3e) and SMMC7721 (Fig. 3f) cells. Collectively, we concluded that ANRIL knockdown significantly suppressed HCC cell growth, metastasis, and invasion. 
The interaction between ANRIL and miR-122-5p in HCC cells
Increasing evidence has suggested that lncRNA might serve as a ceRNA or a molecular sponge in suppressing the biological activities and expressions of miRNAs Tan et al. 2015) . To explore whether ANRIL had a similar regulatory role on miRNAs, online software program Starbase 2.0 (http://starbase.sysu.edu.cn/mirLncRNA.php) was performed to predict the potential miRNAs that interacted with ANRIL. As illustrated in Fig. 4a , miR-122-5p was predicted to contain complementary base pairing with ANRIL. To confirm the direct binding between ANRIL and miR-122-5p at endogenous levels, we performed anti-MS2 RIP to pull down endogenous miRNAs associated with ANRIL and demonstrated by qRT-PCR that the ANRIL RIP in HepG2 and SMMC7721 cells was significantly enriched for miR-122-5p compared with IgG, the empty vector (MS2), and ANRIL with mutation in miR-122-5p-targeting sites (named ANRIL-MUT) (Fig. 4b) . Moreover, luciferase reporter vectors containing the predicted wild-type or mutated miR-122-5p-binding sites in ANRIL (ANRIL-WT or ANRIL-MUT) were constructed and cotransfected with miR-122-5p or miR-NC into HepG2 and SMMC7721 cells. As shown in Fig. 4c , miR-122-5p overexpression significantly decreased the luciferase activity of pmirGLO-ANRIL-WT in HepG2 and SMMC7721 cells, but exerted no obvious inhibitory effect on pmirGLO-ANRIL-MUT. To further explore whether ANRIL could regulate the expression of miR-122-5p in HCC cells, HepG2 and SMMC7721 cells were transfected with si-ANRIL, pcDNA-ANRIL, or respective controls. The qRT-PCR results showed that the expression level of miR-122-5p was significantly increased in si-ANRIL-transfected HepG2 and SMMC7721 cells compared with si-NC group and markedly decreased in pcDNA-ANRIL-transfected HepG2 and SMMC7721 cells in contrast to pcDNA-transfected cells (Fig. 4d) . Collectively, we concluded that ANRIL functioned as a molecular sponge of miR-122-5p in HCC.
The effect of cotransfection of miR-122-5p with pcDNA-ANRIL on HCC cell proliferation, metastasis, and invasion
To further explore whether ANRIL exerted its biological roles through miR-122-5p, HepG2 cells were transfected with miR-122-5p, miR-NC, or along with pcDNA-ANRIL or pcDNA. As demonstrated by MTT assay, ectopic expression of miR-122-5p led to an obvious suppression on cell viability in HepG2 cells, whereas ANRIL overexpression dramatically abolished miR-122-5p-induced inhibition on cell viability (Fig. 5a) . Consistently, the colony number in miR-122-5p-overexpressing HepG2 cells was conspicuously decreased, while forced expression of ANRIL abrogated the inhibitory effect on colony formation by miR-122-5p (Fig. 5b) , as illustrated by colony formation assay. In addition, wound healing assay revealed that exogenous expression of miR-122-5p strikingly impeded the metastasis of HepG2 cells, while ANRIL overexpression significantly reversed miR-122-5p-induced inhibition of metastasis (Fig. 5c) . Meanwhile, transwell invasion assay demonstrated that restoration of miR-122-5p expression effectively repressed cell invasion of HepG2 cells; however, enforced expression of ANRIL recuperated the cell invasive ability in miR-122-5p-overexpressing cells (Fig. 5d) . Together, these results demonstrated that ANRIL overexpression reversed the inhibitory effect of miR-122-5p on HCC cell proliferation, metastasis, and invasion.
The effect of ANRIL knockdown on tumor growth and miR-122-5p expression in HCC cells in vivo
To further confirm the biological significance of ANRIL on tumorigenesis in vivo, we established a xenograft tumor mice model by subcutaneously injecting HepG2 cells transfected with sh-ANRIL or sh-NC into either side of flank area of nude mice. Tumor volumes were measured once every 5 days for 35 days and the tumor growth curve showed that ANRIL knockdown significantly suppressed tumor growth, as compared with the sh-NC group (Fig. 6a) . The mice were killed at 35 days after injection and xenografts were dissected and weighted. As illustrated in Fig. 6b , the average tumor weight in sh-ANRIL group was conspicuously lower than that in sh-NC group. Furthermore, the expression level of miR-122-5p in tumor xenograft tissues was examined by qRT-PCR and the results demonstrated that ANRIL knockdown led to a marked increase of miR-122-5p in contrast to sh-NC-transfected cells (Fig. 6c) . Together, these data indicated that ANRIL knockdown suppressed tumor growth and induced miR-122-5p expression in HCC cells in vivo.
Discussion
Increasing studies have highlighted the biological roles of lncRNAs in caicinogenesis, and provided new insights into the underlying molecular mechanisms by which lncRNAs involved in the pathogenesis and development of multiple type of human cancers Yang et al. 2016; Zhuang et al. 2016) . However, the molecular mechanism of ANRIL in HCC tumorigenesis remains to be completely illustrated. In our study, we provided evidence that ANRIL was aberrantly upregulated and played an oncogenic role in HCC tumorigenesis. ANRIL was demonstrated to directly interact with miR-122-5p and negatively regulate its expression. ANRIL exerting the oncogenic role to promote HCC tumorigenesis was partially attributed to its ability to serve as a molecular sponge for miR-122-5p. Hence, our study may contribute to an increasing of the literatures supporting the significance of lncRNA species in cancer treatment. ) transfected with sh-ANRIL or sh-NC were subcutaneously injected into either side of flank area of nude mice (n = 4 per group) and then housed in specific pathogen free facilities. a Tumor volumes were measured once every 5 days for 35 days. b Mice were killed at 35 days after injection and xenografts were dissected and weighted. c Relative expression of miR-122-5p in tumor xenograft tissues was examined by qRT-PCR. *P < 0.05
To date, increasing evidence has demonstrated that aberrant expression of lncRNAs plays a critical role in the tumorigenesis and development of HCC. For example, high expression of lncRNA colon cancer-associated transcript 2 (CCAT2) was associated with poor survival in HCC patients and knockdown of CCAT2 reduced HCC cell metastasis and invasion by regulating transcription factor snail2-induced epithelial-mesenchymal transition (EMT) (Xu et al. 2017 ). In addition, lncRNA nuclear-enriched abundant transcript 1 (NEAT1) was upregulated in HCC tissues and knockdown of NEAT1 reduced HCC cell proliferation, invasion, and metastasis (Mang et al. 2017) . Moreover, upregulation of lncRNA human ovarian cancer-specific transcript 2 (HOST2) promoted cell proliferation, metastasis, and invasion and inhibited cell apoptosis in human HCC cells (Liu et al. 2017) . Increasing evidence has indicated that ANRIL exerts oncogenic activity in several types of human solid carcimomas, such as epithelial ovarian cancer, non-small cell lung cancer (NSCLC), colorectal cancer, and other cancers (Lu et al. 2016; Qiu et al. 2016; Sun et al. 2016; Zhu et al. 2015a) . Of note, it was reported that ANRIL was significantly highly expressed in HCC tissues and contributed to HCC tumorigenesis both in vitro and in vivo by promoting cell proliferation and invasion and inhibiting cell apoptosis (Hua et al. 2015; Huang et al. 2015b ). In accordance with these previous studies, the present study showed that ANRIL was significantly upregulated in HCC tissues and cells. Loss-of-function analyses demonstrated that ANRIL knockdown distinctively suppressed HCC cell viability, colony formation ability, metastasis, and invasion. Furthermore, in vivo experiment verified that ANRIL knockdown remarkably suppressed tumor growth in nude mice. These results suggested that ANRIL played an oncogenic role in HCC tumorigenesis.
Although ANRIL was demonstrated to function as an oncogene in HCC, the molecular mechanism by which ANRIL involved in the development of HCC is still unclear. Mechanistic analysis in the present study found that ANRIL promoted HCC progression by functioning as a ceRNA to regulate miR-122-5p. It is well documented that lncRNAs play a crucial role in the pathogenesis and development of human malignancies by serving as a ceRNA to bind to miRNAs and regulate their function, such as CASC2 , PVT1 (Li et al. 2017) , and TUG1 (Ma et al. 2017) . In the present study, a negative correlation between ANRIL and miR-122-5p expression was observed in HCC tissues. In addition, we found that ANRIL is involved in the ceRNA regulatory network and acted as a molecular sponge of miR-122-5p and repressed miR-122-5p expression. It has been proposed that miR-122, the most abundant miRNA in the liver, is downregulated and acts as a tumor suppressor in many kinds of tumors, such as HCC , gallbladder carcinoma (Lu et al. 2015) , breast cancer (Ergun et al. 2015) , and so on. Furthermore, ANRIL overexpression recuperated the inhibitory effect of ectopic expression of miR-122-5p on HCC cell viability, colony formation ability, metastasis, and invasion, suggesting that ANRIL exerted its oncogenic role in HCC progression by regulating miR-122-5p.
In conclusion, we demonstrated that ANRIL was significantly upregulated in HCC tissues and cells and negatively correlated with miR-122-5p expression. Furthermore, ANRIL knockdown suppressed HCC cell growth, metastasis, and invasion by acting as a molecular sponge of miR-122-5p, illustrating the underlying mechanism of the oncogenic role of ANRIL in HCC.
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